Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06894212 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 522 participants |
| Active Locations | 36 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06894212 is currently recruiting participants. This clinical trial study for schizophrenia is actively seeking new participants at 36 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06894212 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 36 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06894212 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.